Subscribe

News
Media
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Sukeina Nasser, PharmD, RPh, CPh, PACS

Articles by Sukeina Nasser, PharmD, RPh, CPh, PACS

Hairy cell leukemia -- Image credit: Dr_Microbe | stock.adobe.com

Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia Treatment

ByHusna Rahim, PharmD, RPh,Sukeina Nasser, PharmD, RPh, CPh, PACS,Rezarta Lako, PharmD, BCPS,Richa Shah, PharmD, BCOP,Jessie Modlin, PharmD, BCOP,Avani Yenamandra, PharmD, BCOP,Kevin Pang, PharmD

February 24th 2025

BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.

Latest Updated Articles

Trending on Pharmacy Times

States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments

FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension

Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma

Study Shows Growing Confidence in Cell and Gene Therapies Across the Care Continuum

Hyperlipidemia Causally Linked to Increased Risk of Alzheimer Disease

© 2025 MJH Life Sciences^®

All rights reserved.